Search Results
Aug 07, 2026, 16:15 ET Havertys Furniture Third Quarter 2026 Cash Dividend and Additional Authorization Under Stock Repurchase Program
ATLANTA, Aug. 7, 2026 /PRNewswire/ -- Haverty Furniture Companies, Inc. (NYSE: HVT and HVT.A) ("Havertys" or the "Company") today announced that its Board of Directors declared a cash dividend to be paid on the outstanding shares of
More news about: Haverty Furniture Companies, Inc.
Aug 04, 2026, 06:45 ET Havertys Furniture Reports Operating Results for Second Quarter 2026
ATLANTA, Aug. 4, 2026 /PRNewswire/ -- Haverty Furniture Companies, Inc. (NYSE: HVT and HVT.A), today reported operating results for the second quarter ended June 30, 2026.
More news about: Haverty Furniture Companies, Inc.
Jul 28, 2026, 16:15 ET Havertys Furniture To Announce Second Quarter 2026 Results on August 4, 2026
ATLANTA, July 28, 2026 /PRNewswire/ -- HAVERTY FURNITURE COMPANIES, INC. (NYSE: HVT and HVT.A) will release its second quarter 2026 financial results on Tuesday, August 4, 2026, before the market opens, followed by a conference call
More news about: Haverty Furniture Companies, Inc.
Apr 21, 2026, 16:15 ET Vapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients
enabling HVT 2.0 to support neonatal to adult patients with a single disposable circuit, we are helping healthcare teams deliver high velocity therapy more efficiently while maintaining the comfort and noninvasive approach Vapotherm is known for."The APC is designed for use with the HVT 2.0 platform
More news about: Vapotherm, Inc.
Oct 27, 2025, 16:30 ET Vapotherm HVT® 2.0 Earns DoD Authority to Operate Certification, Advancing Secure Respiratory Support for Military and VA Hospitals
global leader in mask-free noninvasive respiratory support, announced its HVT® 2.0 system has received Authority to Operate (ATO) certification under the Department of Defense's (DoD) Risk Management Framework (RMF). HVT 2.0 is uniquely positioned to deliver its high velocity therapy, and continues
More news about: Vapotherm, Inc.